Skip to main content

Evolving chronic disease management in HIV care in an era of improved long-term survival

Abstract

Background

Adults ageing with HIV and on antiretroviral therapy have a greater burden of chronic diseases compared with adults without HIV as reported by Althoff et al. (Curr Opin HIV AIDS 11:527–36, 2016). Therefore, it is important in this clinically stable HIV+ population to monitor and evaluate their risk of chronic kidney disease and intervene when appropriate. The European AIDS Clinical Society (EACS) advise that yearly screening for CKD with eGFR calculation and spot urine protein measurements should be performed (European AIDS Clinical Society Guidelines 2018). The Centre for Excellence for Health, Immunity and Infection (CHIP) have created a validated study calculator to estimate a patient’s risk for CKD as reported by Mocroft et al. (PLoS Med 12(3):e1001809, 2015).

Aims

(1) To determine the proportion of patients who had a urinary protein-creatinine ratio checked in 2018; (2) To calculate an eGFR for each patient in our cohort utilizing the Modification of Diet in Renal Disease (MDRD) calculation; (3) To calculate the full chronic kidney disease score in our cohort of patients.

Methods

We undertook a retrospective chart review of 80 HIV-positive patients who attended our weekly clinic in Beaumont Hospital, Dublin, Ireland.

Results

In our subset of 31 patients who had all the requirements to estimate their eGFR and full chronic kidney disease risk score, 100% (31/31) of eGFRs calculated were reported as > 90 mL/min/1.73 m2. The median eGFR was 215 mL/min/1.73 m2 (range 95.69–418.08 mL/min/1.73 m2). The average CHIP full chronic kidney disease 5-year risk score for patients developing CKD was 0.91% (95% CI 0.60–1.21%). One patient was identified with a risk score of 5.05% as they had suffered an acute coronary syndrome event in the past.

Conclusion

Although this audit was small and with limitations, it highlights the importance of collecting relevant and accurate patient data annually to estimate and mitigate the risk of chronic kidney disease in patients with HIV.

This is a preview of subscription content, access via your institution.

References

  1. HSE Health Protection Surveillance Centre (2018) HIV in Ireland, 2017. HSE HPSC, Dublin

    Google Scholar 

  2. Beaumont Hospital internal audit data

  3. Althoff K, Smit M, Reiss P, Justice AC (2016) HIV and ageing: improving quantity and quality of life. Curr Opin HIV AIDS 11:527–536

    Article  Google Scholar 

  4. Althoff KN, Gebo KA, Moore RD, Boyd CM, Justice AC, Wong C., ... & Silverberg MJ (2019) Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies. The Lancet HIV

  5. Smith CJ, Ryom L, Weber R, Morlat P, Pradier C, Reiss P, Kowalska JD, de Wit S, Law M, el Sadr W, Kirk O, Friis-Moller N, Monforte A'A, Phillips AN, Sabin CA, Lundgren JD (2014) Trends in underlying causes of death in people with HIV from 1999 to 2011 [D:A:D]: a multicohort collaboration. Lancet 384:241–248

    Article  Google Scholar 

  6. Winston JA (2010) HIV and CKD epidemiology. Adv Chronic Kidney Dis 17(1)

    Article  Google Scholar 

  7. Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O et al (2015) Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D: A: D study. PLoS Med 12(3):e1001809

    Article  Google Scholar 

  8. European AIDS Clinical Society Guidelines 2018 V9.1 Part III Pg 52

  9. HSE (2017) Health Protection Surveillance Centre continuum of HIV care, Ireland

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to James O’Connell.

Ethics declarations

Conflict of interest

Prof. Samuel McConkey has received research grants from Gilead. There are no other potential conflicts of interest to disclose.

Ethical approval

The results presented are those of a clinical audit which was registered with the Beaumont Hospital clinical audit committee and adherent to the standards set by that committee.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Vijh, R., O’Connell, J., de Barra, E. et al. Evolving chronic disease management in HIV care in an era of improved long-term survival. Ir J Med Sci 189, 337–339 (2020). https://doi.org/10.1007/s11845-019-02063-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-019-02063-y